Total Payments
$3,194
2024 Payments
$310.68
Companies
14
Transactions
38
Medicare Patients
1,328
Medicare Billing
$105,023
Payment Breakdown by Category
Food & Beverage$3,175 (99.4%)
Gifts$19.40 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,175 | 37 | 99.4% |
| Gift | $19.40 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $633.11 | 11 | $0 (2021) |
| CooperVision Inc. | $414.30 | 6 | $0 (2024) |
| Allergan Inc. | $341.78 | 3 | $0 (2018) |
| Shire North American Group Inc | $320.57 | 3 | $0 (2019) |
| Alcon Laboratories Inc | $284.60 | 3 | $0 (2017) |
| Regeneron Healthcare Solutions, Inc. | $232.71 | 2 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $223.86 | 2 | $0 (2024) |
| Alcon Vision LLC | $139.27 | 2 | $0 (2023) |
| Tarsus Pharmaceuticals, Inc. | $137.81 | 1 | $0 (2024) |
| MacuLogix, Inc. | $134.03 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $310.68 | 3 | Tarsus Pharmaceuticals, Inc. ($137.81) |
| 2023 | $220.71 | 2 | Alcon Vision LLC ($121.85) |
| 2022 | $240.74 | 2 | Sun Pharmaceutical Industries Inc. ($125.00) |
| 2021 | $122.27 | 2 | CooperVision Inc. ($98.08) |
| 2020 | $112.56 | 3 | CooperVision Inc. ($69.27) |
| 2019 | $588.47 | 8 | Bausch & Lomb, a division of Bausch Health US, LLC ($383.15) |
| 2018 | $898.77 | 11 | Allergan Inc. ($216.78) |
| 2017 | $700.00 | 7 | Alcon Laboratories Inc ($284.60) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $137.81 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/20/2024 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $47.87 | General |
| Category: Devices | ||||||
| 11/07/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 05/30/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $121.85 | General |
| Category: Ophthalmology | ||||||
| 04/13/2023 | Bausch & Lomb Americas Inc. | — | Food and Beverage | In-kind items and services | $98.86 | General |
| 06/15/2022 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
| 05/20/2022 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $115.74 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2021 | CooperVision Inc. | MiSight Contact Lens (Device) | Food and Beverage | In-kind items and services | $98.08 | General |
| Category: Devices | ||||||
| 07/07/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | INFUSE (Device) | Food and Beverage | In-kind items and services | $24.19 | General |
| Category: Ophthalmology | ||||||
| 07/15/2020 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/08/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 01/29/2020 | CooperVision Inc. | Multiple Brands Contact Lens (Device) | Food and Beverage | Cash or cash equivalent | $69.27 | General |
| Category: Devices | ||||||
| 11/21/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/06/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device), ULTRA | Food and Beverage | In-kind items and services | $31.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/27/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device) | Food and Beverage | In-kind items and services | $44.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | BIOTRUE ONE DAY (Device) | Food and Beverage | In-kind items and services | $107.30 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/18/2019 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $102.62 | General |
| Category: OPTHALMICS | ||||||
| 05/15/2019 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $85.28 | General |
| Category: Devices | ||||||
| 03/21/2019 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/16/2019 | Alcon Vision LLC | ReSTOR (Device) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Ophthalmology | ||||||
| 12/04/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | BTOD (Device), ULTRA | Food and Beverage | In-kind items and services | $36.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2018 | Regeneron Healthcare Solutions, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $116.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/05/2018 | CooperVision Inc. | Clariti Contact Lens (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Devices | ||||||
| 07/05/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $102.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/07/2018 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $96.69 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 117 | 158 | $19,279 | $9,139 |
| 2022 | 10 | 358 | 458 | $57,070 | $29,071 |
| 2021 | 11 | 396 | 459 | $57,719 | $30,059 |
| 2020 | 12 | 457 | 543 | $73,226 | $36,755 |
Total Patients
1,328
Total Services
1,618
Medicare Billing
$105,023
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 23 | $4,485 | $2,977 | 66.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 20 | 20 | $2,758 | $1,945 | 70.5% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 22 | 27 | $2,835 | $1,264 | 44.6% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 21 | 48 | $5,040 | $1,190 | 23.6% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 12 | 15 | $1,536 | $967.40 | 63.0% |
| 92065 | Eye training exercise performed by health care professional | Office | 2023 | 21 | 25 | $2,625 | $796.25 | 30.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 84 | 85 | $12,335 | $7,385 | 59.9% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 58 | 82 | $9,020 | $4,988 | 55.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 25 | 32 | $6,240 | $4,323 | 69.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $3,825 | $2,571 | 67.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 35 | 86 | $9,030 | $2,196 | 24.3% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 37 | 46 | $4,830 | $2,190 | 45.3% |
| 92065 | Eye training exercises | Office | 2022 | 38 | 46 | $4,830 | $1,861 | 38.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 14 | 14 | $2,310 | $1,594 | 69.0% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 27 | 27 | $2,700 | $1,306 | 48.4% |
| 92133 | Imaging of optic nerve | Office | 2022 | 25 | 25 | $1,950 | $656.74 | 33.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 129 | 130 | $18,850 | $11,197 | 59.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 73 | 106 | $11,660 | $6,334 | 54.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 45 | 45 | $7,425 | $3,843 | 51.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 13 | 16 | $3,120 | $2,282 | 73.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 32 | 34 | $3,400 | $1,534 | 45.1% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 18 | 25 | $2,625 | $1,235 | 47.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $2,325 | $1,040 | 44.7% |
| 92065 | Exercises to correct eyeball muscle imbalances | Office | 2021 | 18 | 24 | $2,520 | $1,005 | 39.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 13 | 24 | $2,830 | $628.39 | 22.2% |
About Dr. Julie Lam, O.D
Dr. Julie Lam, O.D is a Optometrist healthcare provider based in Cave Creek, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1972731701.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Lam, O.D has received a total of $3,194 in payments from pharmaceutical and medical device companies, with $310.68 received in 2024. These payments were reported across 38 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,175).
As a Medicare-enrolled provider, Lam has provided services to 1,328 Medicare beneficiaries, totaling 1,618 services with total Medicare billing of $105,023. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Cave Creek, AZ
- Active Since 07/01/2009
- Last Updated 01/14/2019
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1972731701
Products in Payments
- XIIDRA (Drug) $320.57
- VYZULTA (Drug) $296.69
- Clariti Contact Lens (Device) $246.95
- BIOTRUE ONE DAY (Device) $245.44
- DAILIES (Device) $157.85
- XDEMVY (Drug) $137.81
- AdaptDx (Device) $134.03
- AcrySof (Device) $126.75
- Cequa (Drug) $125.00
- MIEBO (Drug) $125.00
- HYDRUS Microstent (Device) $121.85
- EYLEA AFLIBERCEPT INJECTION (Biological) $116.97
- EYLEA (Biological) $115.74
- RESTASIS (Drug) $114.54
- LUMIGAN (Drug) $102.24
- ZYLET (Drug) $99.79
- MiSight Contact Lens (Device) $98.08
- XR (Device) $87.97
- Multiple Brands Contact Lens (Device) $69.27
- BTOD (Device) $36.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.